Osteoporosis post-menopausal and Oesophagitis

Summary:

Oesophagitis is found among people with Osteoporosis post-menopausal, especially for people who are female, 60+ old.

The study analyzes which people have Oesophagitis with Osteoporosis post-menopausal. It is created by eHealthMe based on reports of 21 people who have Osteoporosis post-menopausal from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Osteoporosis post-menopausal?

Osteoporosis post-menopausal (weak bone with possibility to break after stopped menstrual cycles) is found to be associated with 42 drugs and 110 conditions by eHealthMe. Check the latest studies of Osteoporosis post-menopausal.

What is Oesophagitis?

Oesophagitis (inflammation of oesophagus) is found to be associated with 1,183 drugs and 1,066 conditions by eHealthMe. Check the latest studies of Oesophagitis.



On Jul, 29, 2026

21 people who have Osteoporosis Post-Menopausal and Oesophagitis are studied.

Would you have Oesophagitis when you have Osteoporosis post-menopausal?

Gender of people who have Osteoporosis Post-Menopausal and experienced Oesophagitis *:

  • female: 90.48 %
  • male: 9.52 %

Age of people who have Osteoporosis Post-Menopausal and experienced Oesophagitis *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 11.76 %
  • 60+: 88.24 %

Common co-existing conditions for these people *:

  1. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 14.29%
  2. Chronic Thyroiditis (long lasting inflammation of thyroid gland): 3 people, 14.29%
  3. Arrhythmias (irregular heartbeat): 3 people, 14.29%
  4. Type 1 Diabetes: 2 people, 9.52%
  5. Sleep Apnea Syndrome: 1 person, 4.76%
  6. Quit Smoking: 1 person, 4.76%
  7. Osteoporosis (bones weak and more likely to break): 1 person, 4.76%
  8. Osteopenia (a condition where bone mineral density is lower than normal): 1 person, 4.76%
  9. Hypersensitivity: 1 person, 4.76%
  10. High Blood Pressure: 1 person, 4.76%

Common drugs taken by these people *:

  1. Prolia: 12 people, 57.14%
  2. Calcium: 6 people, 28.57%
  3. Vytorin: 3 people, 14.29%
  4. Avapro: 3 people, 14.29%
  5. Tenormin: 3 people, 14.29%
  6. Norvasc: 2 people, 9.52%
  7. Omeprazole: 2 people, 9.52%
  8. Glyburide: 2 people, 9.52%
  9. Fosamax: 2 people, 9.52%
  10. Glucophage: 1 person, 4.76%

Common symptoms for these people *:

  1. Diarrhea: 6 people, 28.57%
  2. Malaise (a feeling of general discomfort or uneasiness): 5 people, 23.81%
  3. Chest Pain: 5 people, 23.81%
  4. Gastritis (inflammation of stomach): 4 people, 19.05%
  5. Dizziness: 4 people, 19.05%
  6. Pain: 4 people, 19.05%
  7. Stress And Anxiety: 4 people, 19.05%
  8. Cough: 4 people, 19.05%
  9. High Blood Pressure: 4 people, 19.05%
  10. Arrhythmias (irregular heartbeat): 4 people, 19.05%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Oesophagitis?

- Check whether Oesophagitis is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Oesophagitis:

All the conditions that are associated with Oesophagitis:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Oesophagitis and Osteoporosis post-menopausal, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: